Pulse Biosciences posts investor deck detailing progress on nPulse devices

PULSE BIOSCIENCES, INC.

Updated investor presentation highlights recent progress on nPulse Vybrance Percutaneous Electrode, Cardiac Clamp, and Cardiac Catheter.
Presentation posted January 14, 2026; company expects to use it in investor meetings and analyst calls.
Deck available on company website under Investors section; no financial or clinical data disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.